PALO ALTO, Calif., Nov. 14, 2023 /PRNewswire/ — Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and financial results for the quarter ended September 30, 2023. “We have three retinal disease prospects in our pipeline: two molecules built with our antibody…